INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis
USA - NASDAQ:ISRG - US46120E6023 - Common Stock
546.51 USD
-4.79 (-0.87%)
545.007 USD
-1.5 (-0.28%)
Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 189 industry peers in the Health Care Equipment & Supplies industry. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ISRG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year ISRG was profitable.
ISRG had a positive operating cash flow in the past year.
In the past 5 years ISRG has always been profitable.
In the past 5 years ISRG always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.93%, ISRG belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.61%, ISRG belongs to the top of the industry, outperforming 90.53% of the companies in the same industry.
The Return On Invested Capital of ISRG (12.92%) is better than 92.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ISRG is above the industry average of 9.00%.
The last Return On Invested Capital (12.92%) for ISRG is above the 3 year average (12.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROIC | 12.92% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
ISRG has a Profit Margin of 28.51%. This is amongst the best in the industry. ISRG outperforms 95.79% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.96%, ISRG belongs to the top of the industry, outperforming 96.84% of the companies in the same industry.
ISRG's Operating Margin has declined in the last couple of years.
ISRG has a better Gross Margin (66.61%) than 71.58% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
Compared to 1 year ago, ISRG has more shares outstanding
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ISRG has an Altman-Z score of 52.56. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ISRG (52.56) is better than 99.47% of its industry peers.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 52.56 |
ROIC/WACC1.49
WACC8.66%
2.3 Liquidity
A Current Ratio of 5.17 indicates that ISRG has no problem at all paying its short term obligations.
The Current ratio of ISRG (5.17) is better than 79.47% of its industry peers.
ISRG has a Quick Ratio of 4.18. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.18, ISRG is doing good in the industry, outperforming 78.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
Measured over the past years, ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.53% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.89% yearly.
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 63.47 indicates a quite expensive valuation of ISRG.
Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than the industry average as 67.37% of the companies are valued more expensively.
ISRG is valuated expensively when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 57.75, the valuation of ISRG can be described as expensive.
Based on the Price/Forward Earnings ratio, ISRG is valued a bit cheaper than 67.37% of the companies in the same industry.
ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.47 | ||
| Fwd PE | 57.75 |
4.2 Price Multiples
64.74% of the companies in the same industry are more expensive than ISRG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 69.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 98.24 | ||
| EV/EBITDA | 58.46 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.7
PEG (5Y)5.53
EPS Next 2Y13.63%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
546.51
-4.79 (-0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change-0.37%
Ins Owners0.45%
Ins Owner Change0.86%
Market Cap195.91B
Revenue(TTM)9.61B
Net Income(TTM)2.61B
Analysts79
Price Target597.45 (9.32%)
Short Float %2.31%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)0%
PT rev (3m)-0.26%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)4.02%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.47 | ||
| Fwd PE | 57.75 | ||
| P/S | 21.42 | ||
| P/FCF | 98.24 | ||
| P/OCF | 69.32 | ||
| P/B | 10.98 | ||
| P/tB | 11.21 | ||
| EV/EBITDA | 58.46 |
EPS(TTM)8.61
EY1.58%
EPS(NY)9.46
Fwd EY1.73%
FCF(TTM)5.56
FCFY1.02%
OCF(TTM)7.88
OCFY1.44%
SpS25.51
BVpS49.78
TBVpS48.76
PEG (NY)4.7
PEG (5Y)5.53
Graham Number98.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROCE | 14.34% | ||
| ROIC | 12.92% | ||
| ROICexc | 18.33% | ||
| ROICexgc | 18.86% | ||
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% | ||
| FCFM | 21.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 144.66% | ||
| Cap/Sales | 9.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.68% | ||
| Profit Quality | 76.48% | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 52.56 |
F-Score6
WACC8.66%
ROIC/WACC1.49
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
EBIT growth 1Y34.8%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 8 / 10.